{"organizations": ["Telesta Therapeutics"], "uuid": "84c17247965ff7996a5cbf7053e7e92a8829f56b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.pharmamedtechbi.com", "main_image": "", "site_section": "http://feeds.feedburner.com/PharmaBiotechFinancing", "section_title": "Pharma/Biotech Financing From Elsevier Business Intelligence", "url": "https://www.pharmamedtechbi.com/deals/201530644?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "country": "IL", "title": "Telesta Therapeutics raises $28.3mm through private placement", "performance_score": 0, "site": "pharmamedtechbi.com", "participants_count": 0, "title_full": "Telesta Therapeutics raises $28.3mm through private placement", "spam_score": 0.0, "site_type": "news", "published": "2015-08-21T02:40:00.000+03:00", "replies_count": 0, "uuid": "84c17247965ff7996a5cbf7053e7e92a8829f56b"}, "author": "", "url": "https://www.pharmamedtechbi.com/deals/201530644?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "ord_in_thread": 0, "title": "Telesta Therapeutics raises $28.3mm through private placement", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Telesta Therapeutics raises $28.3mm through private placement Deal Date: Aug-01-2015 / Deal # 201530644 Executive Summary \nTelesta Therapeutics Inc. (developing MCNA (Mycobacterium phlei cell wall-nucleic acid complex) for non-muscle invasive bladder cancer) raised $28.3mm through the private sale of 109mm common shares at $0.26 (market average).Consonance Capital Investors purchased almost half of the shares (and now holds a 19.96% stake), and was joined by Boxer Capital (of Tavistock Life Sciences) and Omega Funds, along with members of Telesta's senior management team and board of directors.", "external_links": [], "published": "2015-08-21T02:40:00.000+03:00", "crawled": "2015-08-21T18:04:43.697+03:00", "highlightTitle": ""}